Predictive Payer Coverage Reports

Prior to FDA approval, it is crucial to know how Payers will treat your new therapeutic. Our Predictive Payer Coverage Reports offer proprietary insights on relevant coverage, restrictions, criteria and payer policy adoption across the payer landscape to support your market access strategy at launch.

The Burning Questions we Answer for You/The Highlights:

1

Which Payers are most likely to cover

2

What restrictions are most likely to be in place

3

Are there certain HTAs, studies or guidelines that will influence your coverage

4

How will Payer contracting influence formulary position and preferred status

From FDA Approval to Initial Coverage, a Detailed Analysis:

Predictive Coverage Reports seek to arm you with the knowledge you need to make your therapy succeed, our thorough analysis provides:

Predicted coverage, criteria, restriction and preferred status by Payer, geography, and plan type

Summary Dashboards to allow for easy data navigation

A detailed analysis on a Payer by Payer and Plan by Plan basis

Criteria and restriction predictions

Post-approval scenarios

Contracting insights

Market Access Strategy

Payer advocacy strategy

Sample Coverage Policy

Ready to get started?

Get ahead of the market using crucial insights with a Predictive Coverage Report. Get in touch with us today to book a consultation with our experienced Data Analysis and Market Access Team.

Book a demo

Predictive Payer Coverage Reports

The Burning Questions we Answer for You/The Highlights:

Which Payers are most likely to cover

What restrictions are most likely to be in place

Are there certain HTAs, studies or guidelines that will influence your coverage

How will Payer contracting influence formulary position and preferred status

From FDA Approval to Initial Coverage, a Detailed Analysis:

Policy Reporter

Services

Company